|
|
|
|
|
00000cam0a22000004ib4500 |
| 001 |
BY-NLB-br246376 |
| 005 |
20070615173452.1 |
| 010 |
# |
# |
$d 400 r.
|
| 100 |
# |
# |
$a 20000211d1975 u y0rusy50 ca
|
| 101 |
0 |
# |
$a eng
|
| 102 |
# |
# |
$a fr
|
| 105 |
# |
# |
$a a 000yy
|
| 109 |
# |
# |
$a da
|
| 200 |
1 |
# |
$a The production and use of cellular blood components for transfusion
$e Report
$f Europ. Publ. Health Comm.
$g Prep.: M.Benbunan et al.
$g Pres.: U.Bucher
|
| 210 |
# |
# |
$a Strasbourg
$c Council of Europe Publ.
$d 1975
|
| 300 |
# |
# |
$a Ref.: p. 58-73
|
| 300 |
# |
# |
$a - Rep. prep. in the framework of the co-ordinated research in blood transfusion (1974 Programme)
|
| 606 |
0 |
# |
$3 BY-NLB-ar7016
$a ГЕМАТОЛОГИЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar15272
$a КРОВЬ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar61473
$a ДОНОРСКАЯ КРОВЬ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar23643
$a ПЛАЗМА КРОВИ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar7017
$a ГЕМАТАЛОГІЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar15273
$a КРОЎ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar23187
$a ПЕРАЛІВАННЕ КРЫВІ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar61474
$a ДОНАРСКАЯ КРОЎ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar14391
$a КАНСЕРВАЦЫЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar23644
$a ПЛАЗМА КРЫВІ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar23186
$a ПЕРЕЛИВАНИЕ КРОВИ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar14390
$a КОНСЕРВАЦИЯ
$2 DVNLB
|
| 675 |
# |
# |
$a 615.38
$v 3
$z rus
|
| 675 |
# |
# |
$a 612.11.08
$v 3
$z rus
|
| 686 |
# |
# |
$a 76.29.33
$2 rugasnti
|
| 686 |
# |
# |
$a 34.39.27
$2 rugasnti
|
| 702 |
# |
1 |
$3 BY-SEK-496146
$a Benbunan
$b M.
|
| 702 |
# |
1 |
$3 BY-SEK-496147
$a Bucher
$b U.
|
| 710 |
0 |
2 |
$3 BY-NLB-ar170066
$a Council of Europe
|
| 711 |
0 |
1 |
$3 BY-SEK-493082
$a European Public Health Committee
|
| 801 |
# |
0 |
$a BY
$b BY-HM0000
$c 20000211
$g psbo
|
| 801 |
# |
1 |
$a BY
$b BY-HM0000
$c 20060315
$g psbo
|
